Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1999
12/09/1999WO1999062923A2 Immunostimulatory oligonucleotides with modified bases and methods of use thereof
12/09/1999WO1999062549A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999WO1999062547A1 HUMAN MINOR VAULT PROTEIN p193
12/09/1999WO1999062546A1 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
12/09/1999WO1999062545A2 GnRH VACCINES FOR SUPPRESSING REPRODUCTIVE BEHAVIOUR IN ANIMALS
12/09/1999WO1999062526A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999WO1999062500A1 Stabilizers for lyophilized vaccines
12/09/1999WO1999051266A3 Derivatives of pneumococcal choline binding proteins for vaccines
12/09/1999WO1999051264A3 Leishmania cysteine proteinases
12/09/1999WO1999048917A3 Formulation having a papilloma virus-specific protein, and the production and use thereof
12/09/1999WO1999047657A3 Lactobacilli harboring aggregation and mucin binding genes as vaccine delivery vehicles
12/09/1999WO1999046594A3 C-myc coding region determinant-binding protein (crd-bp)
12/09/1999WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
12/09/1999WO1999038528A3 Vaccine formulations
12/09/1999WO1999024066A3 Methods and compositions for enhancing immune response and for the production of in vitro mabs
12/09/1999DE19821859A1 Generation of immunogenic capsule polysaccharide-conjugates used to generate vaccines against Neisseria meningitidis
12/09/1999CA2336612A1 Inhibition of viral infection and spread with viral and rhoa-derived peptides
12/09/1999CA2333975A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999CA2333505A1 Stabilizers for lyophilized vaccines
12/09/1999CA2331196A1 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
12/09/1999CA2330833A1 Human minor vault protein p193
12/09/1999CA2330225A1 Immunostimulatory oligonucleotides with modified bases and methods of use thereof
12/09/1999CA2330027A1 Method for preparation and in vivo administration of antigen presenting cell composition
12/09/1999CA2329940A1 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999CA2329527A1 Endometriosis-associated gene
12/08/1999EP0962532A1 Polypeptides and nucleic acids encoding the same for the diagnosis and prevention of tuberculosis disease.
12/08/1999EP0962467A1 Antibody against human parathormone related peptides
12/08/1999EP0961833A1 Human plasma hyaluronidase
12/08/1999EP0961831A1 Human endokine alpha
12/08/1999EP0961826A2 Purification and/or concentration of dna by cross-flow filtration, separation of endotoxins from a nucleic acid preparation
12/08/1999EP0961793A1 Polymers incorporating peptides
12/08/1999EP0961780A1 Protein markers for lung cancer and use thereof
12/08/1999EP0961778A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus
12/08/1999EP0961547A1 NEUTRALIZATION-SENSITIVE EPITOPES OF $i(CRYPTOSPORIDIUM PARVUM)
12/08/1999EP0702565B1 Helicobacter pylori catalase-based immunising composition
12/08/1999EP0640101B1 Methods and reagents for diagnosis of autoantibodies
12/08/1999EP0634934B1 Use of dietary whey proteins for the treatment of hiv-seropositive individuals
12/08/1999EP0600970B1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
12/08/1999EP0522078B1 Gp75 as a tumor vaccine for melanoma
12/08/1999CN1238011A Immunogenic peptides of foot-and-mouth disease viruses
12/08/1999CN1238010A Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
12/08/1999CN1237983A Antibody against human parathormone related peptides
12/08/1999CN1237981A Peptide diagnostic and therapeutic agent for autoimmune diseases
12/08/1999CN1237910A Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies
12/08/1999CN1237909A Cancer immunotherapy using tumor cells combined with mixed lymphocytes
12/08/1999CN1237906A New use for 1,3-propanediol derivatives
12/08/1999CN1237632A Method for preparing rabbitpox culturing tissue containing high-quality physiological activity
12/08/1999CN1237456A Epidemic hemorrhagic fever passage cell polyvalent purified vaccine
12/07/1999US5998601 VR-2332 viral nucleotide sequence and methods of use
12/07/1999US5998588 Interactive molecular conjugates
12/07/1999US5998586 Interleukin-5 specific recombinant antibodies
12/07/1999US5998584 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/07/1999US5998372 Zinc ring protein
12/07/1999US5998205 Vectors for tissue-specific replication
12/07/1999US5998172 Anti-CD6 ligand antibodies
12/07/1999US5998169 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
12/07/1999US5998154 Somatostatin receptor peptide antigens and antibodies
12/07/1999US5998153 Detecting specific binding of the autoantibody in the sample to the epitopic peptide as indicative of the presence of the autoantibody to thyroid peroxidase in the sample from the patient.
12/07/1999US5998130 Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
12/07/1999US5997943 Compound for a non-wettable coating, process for treatment of glass with the aid of the compound and products obtained
12/07/1999US5997882 Epitopic regions of pneumococcal surface protein A
12/07/1999US5997880 Method for alleviating varicella related post-herpetic neuralgia
12/07/1999US5997878 Recombinant poxvirus-cytomegalovirus, compositions and uses
12/07/1999US5997873 Method of preparation of heat shock protein 70-peptide complexes
12/07/1999US5997870 Isolated peptides which bind to HLA-B44 Molecules
12/07/1999US5997869 Peptides containing a fusion joint of a chimeric protein encoded by DNA spanning a tumor-associated chromosomal translocation and their use as immunogens
12/07/1999US5997867 Method of using humanized antibody against CD18
12/07/1999US5997865 Agonist antibodies against the flk2/flt3 receptor and uses thereof
12/07/1999US5997861 Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
12/07/1999US5997859 Gene encoding a conditionally lethal gene product which activates a purine- or pyrimidine-based prodrug into an agent that is cytotoxic to said metastatic carcinoma; and administering said prodrug to said patient
12/07/1999CA2157410C Enhanced circulation effector composition and method
12/07/1999CA2116764C Immunoreactive hepatitis c virus polypeptide compositions
12/07/1999CA2073288C Manipulation of gene copy number in bordetella
12/07/1999CA2015515C Pharmaceutical compositions containing antigen-antibody complexes and uses therefor
12/07/1999CA1340839C Proteins and process for preparing them, dna sequences, antibodies and uses thereof, posvirus, altered or infected cells, pharmaceutical compositions useful for the prevention of schistosomosis and uses thereof as an agent with a glutathion-s-transferase activity
12/07/1999CA1340838C Coccidiosis vacine
12/02/1999WO1999061918A1 Method and means for caries prevention and susceptibility detection
12/02/1999WO1999061916A1 Identification of broadly reactive dr restricted epitopes
12/02/1999WO1999061913A2 Improvements in or relating to diagnosis and treatment of bacterial infections
12/02/1999WO1999061637A1 Gene sequences of rubella virus associated with attenuation
12/02/1999WO1999061636A1 Recombinant cytomegalovirus expression system targeting the immediate-early gene region
12/02/1999WO1999061634A1 Method of producing thy a-strains of vibrio cholerae, such strains and their use
12/02/1999WO1999061626A2 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999WO1999061621A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999WO1999061620A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/02/1999WO1999061618A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999WO1999061614A2 Human socs proteins
12/02/1999WO1999061600A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
12/02/1999WO1999061596A2 Novel post-transcriptional regulatory elements and uses thereof
12/02/1999WO1999061473A1 Method for purification of borrelia lipoprotein ospa
12/02/1999WO1999061470A1 Respiratory nitrate reductase alpha subunit
12/02/1999WO1999061453A2 priA
12/02/1999WO1999061097A2 Alpha emitting constructs and uses thereof
12/02/1999WO1999061085A2 Method and compositions for treatment of cancers
12/02/1999WO1999061065A1 Cd40 binding molecules and ctl peptides for treating tumors
12/02/1999WO1999061056A2 Methods and products for inducing mucosal immunity
12/02/1999WO1999061054A1 Nicotine immunogen
12/02/1999WO1999061053A1 Combination meningitidis b/c vaccines
12/02/1999WO1999061052A2 Oral immunization with papillomavirus virus-like particles
12/02/1999WO1999061051A1 Compositions and methods of modulating an immune response to an antigen
1 ... 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 ... 1823